Searched for
COFEPRIS
Zydus gets Mexican regulatory approval to market cancer treatment productThe product is used in the treatment of breast cancer and advanced gastric cancer. Breast cancer has become the most diagnosed cancer in Me...- Pfizer to seek COVID-19 vaccine approval in Mexico for children aged 12-15"Pfizer will submit the request for authorization from Cofepris for the vaccine, applicable to minors between 12 and 15 years old, in the n...
- Zydus Cadila says 'positive results' from phase 2 studies of COVID-19 drug Desidustat in MexicoIn June 2020, Zydus Cadila had received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate Des...
- Mexico authorizes emergency use of Pfizer-BioNTech coronavirus vaccineThe first 250,000 doses of the mRNA-based vaccine are expected to arrive in Mexico by the end of December and be distributed among medical ...
- Zydus Cadila gets nod from Mexican authority for clinical trials of COVID-19 therapyIn a regulatory filing, Zydus Cadila said it had received approval from the Mexican regulatory authority Cofepris to conduct clinical trial...
- Zydus Cadila gets approval from Mexican authority to test COVID-19 drugLast week, Zydus had received approval from Indian authorities to start human trials for its COVID-19 vaccine contender - the second Indian...
- Zydus gets regulatory nod to market Lipaglyn in MexicoThe company has been granted marketing approval from the Mexican regulatory authority COFEPRIS to commercialise Lipaglyn in Mexico, Zydus s...
- World's first dengue vaccine gets nod after 20 years of researchThe injection can thwart all four types of the virus, which has appeared in Portugal, France, Florida and Japan recently, according to WHO.
- Biocon rallies intraday after getting approval for insulin Glargine in Mexico, but ends in redBiocon rallied a little over 3% in trade on Friday, after the biotechnology major said that it has received approval for its insulin Glargi...
- Biocon gets approval for insulin Glargine in MexicoGalactus by PiSA is the first insulin Glargine to be approved in Mexico as per the biocomparable approvals pathway defined in 2012, it adde...
- Zydus Cadila Q2 net profit up by 94%Besides Lipaglyn, the group launched 19 new products, including line extensions in India of which, four were first in India.
- Venus Remedies gets market authorisation in Mexico for MeropenemThe Panchkula based company plans to launch the drug in 500 mg and 1,000 mg strengths in Mexico, Venus Remedies said in a release.
- Cadila stock touches 52 week high after gettting USFDA approval for two generic drugsAccording to pharma analyst, the company would continue to witness jump in its stock prices as it is bullish on getting FDA approval for it...
- Zydus Cadila's Q1 net profit down by 15.24%Ahmedabad-based Zydus Cadila group reported fall in its consolidated net profit by 15.25% for the first quarter ended on June 30, 2012.
Load More
